Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Agentix's shares outstanding was 40M at Jun 30, 2026. For fiscal 2026 it was 40M, up 0.0% from the year before. The highest annual figure on record is 40M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 40M | 0.0% |
| FY2025 | Mar 31, 2025 | 40M | 0.0% |
| FY2024 | Mar 31, 2024 | 40M | +15.4% |
| FY2021 | Aug 31, 2021 | 35M | +168762.4% |
| FY2019 | Aug 31, 2019 | 0M | +86.3% |
| FY2018 | Aug 31, 2018 | 0M | -1.5% |
| FY2017 | Aug 31, 2017 | 0M | -0.0% |
| FY2016 | Aug 31, 2016 | 0M | +1.0% |
| FY2015 | Aug 31, 2015 | 0M | +8.5% |
| FY2014 | Aug 31, 2014 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | 40M | 0.0% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | 40M | 0.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | 40M | 0.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | 40M | 0.0% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | 40M | 0.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | 40M | 0.0% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | 40M | +14.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | 40M | +14.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | 40M | +16.0% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | 40M | +16.2% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | 35M | +919.2% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | 35M | +25440.0% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | 35M | +153547.5% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | 34M | +3023.8% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | 3M | +209.9% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | 0M | +563.8% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | 0M | +7.7% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | 1M | +9583.4% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | 1M | +9752.9% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | 0M | +83.6% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | 0M | +86.3% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | 0M | +1.7% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | 0M | 0.0% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | 0M | 0.0% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | 0M | -1.0% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | 0M | +0.1% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | 0M | +0.4% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | 0M | +0.4% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | 0M | +1.5% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | 0M | +0.5% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | 0M | +0.6% |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | 0M | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | 0M | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | 0M | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | 0M | – |
See a number that looks wrong?